Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients

NCT04293887 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
328
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tongji Hospital